- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Pretreatment Scanning May Predict IDC Overall Survival
FDG PET/CT scanning before treatment for invasive ductal carcinoma of the breast can predict survival.
Metabolic tumor volume (MTV), determined by FDG PET/CT performed before treatment for invasive ductal carcinoma of the breast (IDC) can predict overall survival, according to a study published in the American Journal of Roentgenology.
Researchers from Korea sought to evaluate the prognostic relevance of PET parameter measured by 18F-FDG PET/CT in patients with IDC the breast who had distant metastasis at the time of initial diagnosis.
The retrospective study included 40 women with IDC, ranging from ages 29 to 75, who had had distant metastasis at the time of initial diagnosis. All had undergone FDG PET/CT before receiving treatment. They also underwent mammography, sonography, bone scan, breast MRI, and conventional contrast-enhanced CT (in the region of metastases) for pretreatment clinical staging.
Treatment for all patients was systemic chemotherapy, hormone therapy, or both as first-line treatment. Thirty-one patients also underwent radiation therapy concurrently with systemic chemotherapy or hormone therapy. In addition, 17 patients with ERBB2–positive breast cancer received trastuzumab, and 15 patients underwent palliative surgery as second-line treatment.
The researchers examined clinicopathologic parameters and metabolic PET parameters, including the maximum standardized uptake value (SUVmax) of the primary tumor (pSUVmax), the SUVmax of the axillary lymph node (nSUVmax), the highest SUVmax of whole malignant lesions (wSUVmax), the whole-body (WB) metabolic tumor volume (MTV), and WB total lesion glycolysis (TLG).
Twenty-one of the 40 patients (52.5%) died during follow-up (mean follow-up, 36.4 months; range, 0.8–71.4 months). “Nonsurvivors had a statistically significantly higher mean (± SD) WB MTV than did survivors (424.0 ± 683.9 versus 92.1 ± 96.3 cm3; p = 0.0430),” the authors wrote.
The researchers concluded that pretreatment FDG PET/CT could determine the WB MTV value, which was found to be an independent prognostic factor for overall survival in patients with IDC who had distant metastasis at the time of initial diagnosis.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
Study Assesses Lung CT-Based AI Models for Predicting Interstitial Lung Abnormality
September 6th 2024A machine-learning-based model demonstrated an 87 percent area under the curve and a 90 percent specificity rate for predicting interstitial lung abnormality on CT scans, according to new research.
